Caron Adds Experienced Life Sciences and Lab Products Executive Mark McLoughlin to Board of Directors News provided by Share this article Share this article MARIETTA, Ohio, May 5, 2021 /PRNewswire/ -- Caron Products and Services ("Caron"), a leading provider of laboratory equipment used in small and large molecule drug development and manufacturing, cell and gene therapy, and academic research, is pleased to announce the appointment of Mark McLoughlin to its Board of Directors. McLoughlin brings more than four decades of relevant operating experience in the laboratory products and life sciences sector. Most recently, he was Executive Vice President for Avantor, and he previously served as of SVP & President, Americas Laboratory and Distribution Services for VWR International, which Avantor acquired. During his tenure at as President for VWR International, McLoughlin was responsible for its Americas $3 billion manufacturing, distribution and services business. He was directly involved in multiple strategic acquisitions and led the integration of these businesses into the Americas portfolio.